Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluatıon of the Effectıveness of Omalızumab Treatment In Patıents Wıth Allergıc Rhınıtıs

NCT06806826 is registered in ClinicalTrials.gov with Yuzuncu Yil University as lead sponsor.

NCT NCT06806826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06806826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluatıon of the Effectıveness of Omalızumab Treatment In Patıents Wıth Allergıc Rhınıtıs
Lead sponsor
Yuzuncu Yil University
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2019
Completion date
March 1, 2020
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic rhinitis